Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

First Quarter Health Care M&A Results

It’s official. The first quarter of 2016 was well off the previous hot-and-heavy pace for health care mergers and acquisitions, which began in 2014. Preliminary data shows 348 transactions were announced in Q1:16, down 7% compared with the fourth quarter of 2015 (375 deals) and down 8% from the same quarter a year ago (377 deals). Deal volume is the real measure, because deal value from month-to-month or quarter-to-quarter is so random. Take the fourth quarter of 2015, for example. Deal volume seemed on pace, but the largest deal in health care M&A history was announced in November, when Pfizer (NYSE: PFE) agreed to pay $160 billion to acquire Allergan plc (NYSE: AGN) for $160 billion,... Read More »

Recent Health Care Deals, week ending 04.01.2016

AcquirerTargetPrice DiaSorin S.p.A.Focus Diagnostics Inc. $300 million Sun Pharmaceutical Industries Ltd.14 prescription drug brands$293 million Encore Rehabilitation Services, LLCContract therapy business$65 million PuraCap PharmaceuticalsEpic Pharma, LLC$550 million MEDNAX, Inc. Mid-Missouri Neonatology,... Read More »

Recent Health Care Deals, week ending 03.25.2016

AcquirerTargetPrice Bristol-Myers Squibb Padlock Therapeutics, Inc. $225 million Capella Healthcare, Inc.$550 million Capitol Senior Living2 assisted living communities$48 million Syncordia Technologies and Healthcare SolutionsBilling Solutions, Inc. $8 million Baptist Health South FloridaNorthpoint Surgery... Read More »

Recent Health Care Deals, week ending 3.18.16

AcquirerTargetPrice Canon Inc.Toshiba Medical Systems $5.9 billion Nautic PartnersExactCare® Pharmacy$150 million Envision Healthcare Holdings, Inc.Emergency Physicians Medical Group $120 million RocheCollaboration on cancer immunotherapy drugs$45 million Microlin Bio, Inc.Nucleic acid therapeutic assets$7.7... Read More »